Jump Trading’s Anavex Life Sciences AVXL Stock Holding History

Jump Trading’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,697	Closed	-$43K	–	238
2018 Q3	$43K	Buy	+15,697	New	+$44.3K	﹤0.01%	424

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jump Trading's AVXL Position: Q4 2018 in Review

Jump Trading sold out of Anavex Life Sciences (AVXL) in Q4 2018, closing a stake of 15,697 shares — an estimated $43K sold.

Jump Trading first reported a position in AVXL in Q3 2018 and held it in 1 quarter. The position peaked at $43K in Q3 2018. 49 funds tracked by Wall St. Rank hold AVXL as of Q4 2018.

Jump Trading reported no remaining Anavex Life Sciences position as of Q4 2018 after selling out during the quarter.
Jump Trading sold 15,697 Anavex Life Sciences shares in Q4 2018, an estimated $43K.
Jump Trading first reported a position in Anavex Life Sciences in Q3 2018 and held it in 1 quarter.
Jump Trading's Anavex Life Sciences position peaked at $43K in Q3 2018.
49 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2018.

Based on Jump Trading's 13F filing for Q4 2018, filed 14 Feb 2019.